Tatyana V. Grebennikova

6 Miklukho Maklaya St
Moscow, MOW 117198, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Boron Clusters Versus Adamantane: A Comparative Study of Inorganic and Organic Scaffolds Against Resistant Influenza A.

Boron Clusters Versus Adamantane: A Comparative Study of Inorganic and Organic Scaffolds Against Resistant Influenza A.

Journal: ChemMedChem

Published: November 19, 2025

Exploring the Anti-Influenza Activity of closo-Borate Platforms: Structure-Activity Relationship of Amino Acid-Functionalized closo-Dodecaborate Derivatives Against Influenza Virus A/Cheboksary/125/2020 (H1N1)pdm09.

Exploring the Anti-Influenza Activity of closo-Borate Platforms: Structure-Activity Relationship of Amino Acid-Functionalized closo-Dodecaborate Derivatives Against Influenza Virus A/Cheboksary/125/2020 (H1N1)pdm09.

Journal: Molecules (Basel, Switzerland)

Published: September 27, 2025

Resistance and chemosensitivity restoration in human cytomegalovirus-infected tumor cells to doxorubicin through combined treatment with aqueous fullerene dC60

Resistance and chemosensitivity restoration in human cytomegalovirus-infected tumor cells to doxorubicin through combined treatment with aqueous fullerene dC60

Journal: Voprosy virusologii

Published: September 26, 2025

Pre-clinical safety studies of intranasal virus-like particles based vaccine for prevention of COVID-19.

Pre-clinical safety studies of intranasal virus-like particles based vaccine for prevention of COVID-19.

Journal: Voprosy virusologii

Published: December 04, 2024

In Vitro Study of Antiviral Properties of Compounds Based on 1,4-Dioxane Derivative of Closo-Decaborate Anion with Amino Acid Ester Residues Against Influenza Virus A/IIV-Orenburg/83/2012(H1N1)pdm09.

In Vitro Study of Antiviral Properties of Compounds Based on 1,4-Dioxane Derivative of Closo-Decaborate Anion with Amino Acid Ester Residues Against Influenza Virus A/IIV-Orenburg/83/2012(H1N1)pdm09.

Journal: Molecules (Basel, Switzerland)

Published: November 09, 2024

Development, production and characterization of SARS-CoV-2 virus-like particles (Coronaviridae: Orthocoronavirinae: Betacoronavirus: Sarbecovirus).

Development, production and characterization of SARS-CoV-2 virus-like particles (Coronaviridae: Orthocoronavirinae: Betacoronavirus: Sarbecovirus).

Journal: Voprosy virusologii

Published: March 21, 2024

Intranasal Ion-Triggered In Situ Delivery System of Virus-like Particles: Development Using the Quality by Design Approach.

Intranasal Ion-Triggered In Situ Delivery System of Virus-like Particles: Development Using the Quality by Design Approach.

Journal: Polymers

Published: January 17, 2024

Compounds based on Adamantyl-substituted Amino Acids and Peptides as Potential Antiviral Drugs Acting as Viroporin Inhibitors.

Compounds based on Adamantyl-substituted Amino Acids and Peptides as Potential Antiviral Drugs Acting as Viroporin Inhibitors.

Journal: Current pharmaceutical design

Published: December 03, 2023

Study of the safety and immunogenicity of VLP-based vaccine for the prevention of rotavirus infection in neonatal minipig model

Study of the safety and immunogenicity of VLP-based vaccine for the prevention of rotavirus infection in neonatal minipig model

Journal: Voprosy virusologii

Published: October 17, 2023

In Vitro Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS-CoV-2.

In Vitro Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS-CoV-2.

Journal: Acta naturae

Published: October 03, 2023

Main Aspects of Pharmaceutical Development of In situ Immunobiological Drugs for Intranasal Administration.

Main Aspects of Pharmaceutical Development of In situ Immunobiological Drugs for Intranasal Administration.

Journal: Current pharmaceutical biotechnology

Published: April 28, 2023

Virus-like particles based on rotavarus A recombinant VP2/VP6 proteins for assessment the antibody immune response by ELISA

Virus-like particles based on rotavarus A recombinant VP2/VP6 proteins for assessment the antibody immune response by ELISA

Journal: Voprosy virusologii

Published: April 17, 2023

Showing 1-12 of 46

Last Updated: 09/26/2026